U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07046195) titled 'Optimal Combination of Adjuvant Radiotherapy and Immunotherapy for Breast Cancer' on June 09.
Brief Summary: Postoperative radiotherapy is a conventional treatment for breast cancer patients with a high risk of recurrence, such as those with regional lymph node metastasis, especially TNBC. However, the optimal mode of treatment for the combination of radiotherapy and immunotherapy has not yet been determined, especially in the adjuvant treatment phase. There is still a lack of validation and high-grade evidence on the safety and synergistic efficacy of radiotherapy-immunotherapy combinations. In this study, we aimed to compare the sa...